Yuyu Pharma, Inc. (000227.KS)
KRW 9750.0
(-0.41%)
KRW 9750.0
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 839.1 Million | -6.22 Billion | 4.5 Billion | -2.66 Billion | 13.18 Billion | 6.11 Billion |
| Net Income | -7.18 Billion | -4.42 Billion | -920.28 Million | 2.41 Billion | 5.56 Billion | 4.31 Billion |
| Depreciation & Amortization | 5.6 Billion | 5.02 Billion | 4.5 Billion | 3.89 Billion | 3.12 Billion | 2.12 Billion |
| Deferred income taxes | - | - | 2.69 Billion | 521.5 Million | 775.54 Million | 1.43 Billion |
| Stock-based compensation | - | - | -42.4 Million | 85.84 Million | 114.17 Million | 178.67 Million |
| Change in working capital | -6.77 Billion | -13.15 Billion | -3.7 Billion | -11.18 Billion | 2.15 Billion | -2.81 Billion |
| Other non-cash items | 9.18 Billion | 6.31 Billion | 1.97 Billion | 1.59 Billion | 1.45 Billion | 876.27 Million |
| Investing Cash Flow | -3.78 Billion | -8.54 Billion | -5.88 Billion | -12.14 Billion | -5.33 Billion | -9.93 Billion |
| Investments in PPE | -5.1 Billion | -5.56 Billion | -6.75 Billion | -14.28 Billion | -8.73 Billion | -10.06 Billion |
| Acquisitions | -770.9 Million | 4.6 Million | 1.02 Billion | 622.05 Million | 1.73 Billion | -54.05 Million |
| Investment purchases | -606.01 Million | -3.83 Billion | -822.32 Million | -1.07 Billion | -1 Billion | -101.91 Million |
| Sales/Maturities of investments | 3.04 Billion | 506 Million | 701.62 Million | 149.5 Million | 1.62 Billion | - |
| Other Investing Activities | -346.4 Million | 346.86 Million | -46.97 Million | 2.45 Billion | 1.04 Billion | 232.13 Million |
| Financing Cash Flow | 7.7 Billion | -9.08 Billion | 31.31 Billion | 8.51 Billion | -8.03 Billion | 10.94 Billion |
| Debt repayment | -10.44 Billion | -6.25 Billion | -906.8 Million | -4.4 Billion | -9.9 Billion | -9.77 Billion |
| Dividends payments | -2 Billion | -2.03 Billion | -1.85 Billion | -1.51 Billion | -1.44 Billion | -1.38 Billion |
| Common Stock Repurchased | - | -1.78 Billion | - | -819.48 Million | - | -976.91 Million |
| Common Stock Issuance | - | - | - | - | - | 23.17 Billion |
| Other Financing Activities | 20.16 Billion | 989.11 Million | 34.07 Billion | 15.25 Billion | 3.31 Billion | -92.8 Million |
| Accounts receivables | 918.93 Million | -1.76 Billion | -3.01 Billion | 316.7 Million | 1.98 Billion | -938.72 Million |
| Accounts payables | -5.52 Billion | 7.09 Billion | 3.71 Billion | -1.04 Billion | 1.34 Billion | -3.38 Billion |
| Inventory | -3.42 Billion | -15.13 Billion | -1.36 Billion | -6.83 Billion | -1.13 Billion | 3.74 Billion |
| Other working capital | 1.25 Billion | -3.34 Billion | -3.03 Billion | -3.61 Billion | -32.7 Million | -6.56 Billion |
| Cash at beginning of period | 25.83 Billion | 50.26 Billion | 20.32 Billion | 26.84 Billion | 26.96 Billion | 19.81 Billion |
| Cash at end of period | 30.6 Billion | 25.83 Billion | 50.26 Billion | 20.32 Billion | 26.84 Billion | 26.96 Billion |
| Capital Expenditure | -5.1 Billion | -5.56 Billion | -6.75 Billion | -14.28 Billion | -8.73 Billion | -10.06 Billion |
| Effect of forex changes on cash | 11.84 Thousand | -568.85 Million | 8.58 Million | -223.54 Million | 63.77 Million | 37.23 Million |
| Net cash flow / Change in cash | 4.76 Billion | -24.42 Billion | 29.94 Billion | -6.52 Billion | -120.31 Million | 7.15 Billion |
| Free Cash Flow | -4.26 Billion | -11.79 Billion | -2.24 Billion | -16.95 Billion | 4.44 Billion | -3.95 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.24 Billion | 5.17 Billion | -1.08 Billion | -7.18 Billion | -2.27 Billion | -3.17 Billion |
| Depreciation & Amortization | 1.43 Billion | 1.39 Billion | 1.45 Billion | 5.6 Billion | 1.4 Billion | 1.44 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.88 Billion | -4.3 Billion | 6.44 Billion | -6.77 Billion | -2.7 Billion | -6.22 Billion |
| Other non-cash items | 2.89 Billion | 5.89 Billion | 2.5 Billion | 9.18 Billion | 1.14 Billion | 2.39 Billion |
| Investing Cash Flow | 583.41 Million | -213.9 Million | -801.2 Million | -3.78 Billion | -11.56 Million | -2.4 Billion |
| Investments in PPE | -180.63 Million | -2.71 Billion | -819.77 Million | -5.1 Billion | -1.34 Billion | -1.6 Billion |
| Acquisitions | -19.95 Million | 2.6 Billion | -825.8 Million | -770.9 Million | 11.9 Million | -366.37 Million |
| Investment purchases | -524.62 Million | -170.97 Million | 886.92 Million | -606.01 Million | 104.26 Million | 513.5 Million |
| Sales/Maturities of investments | 11.82 Million | 28.17 Million | 17.34 Million | 3.04 Billion | -11.9 Million | -353.12 Million |
| Other Investing Activities | 764.04 Million | 41.5 Million | -59.88 Million | -346.4 Million | 1.22 Billion | -594.04 Million |
| Financing Cash Flow | -1.98 Billion | -3.86 Billion | 4.06 Billion | 7.7 Billion | -4.4 Billion | 8.7 Billion |
| Debt repayment | -1.78 Billion | -3.72 Billion | -4.28 Billion | -10.44 Billion | -3.1 Billion | -20.85 Billion |
| Dividends payments | - | - | - | -2 Billion | - | -2 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -194.93 Million | 48 Million | 8.34 Billion | 20.16 Billion | -1.3 Billion | 31.56 Billion |
| Accounts receivables | 929.62 Million | -424.1 Million | 5.1 Billion | 918.93 Million | -5.11 Billion | 62.56 Million |
| Accounts payables | 622.48 Million | -2.91 Billion | 1.78 Billion | -5.52 Billion | -4.72 Billion | -2.14 Billion |
| Inventory | 282.57 Million | 645.77 Million | -1.22 Billion | -3.42 Billion | 5.71 Billion | -3.64 Billion |
| Other working capital | 670.58 Million | -1.61 Billion | 767.32 Million | 1.25 Billion | 1.42 Billion | -499.86 Million |
| Cash at beginning of period | 29.2 Billion | 30.6 Billion | 18.01 Billion | 25.83 Billion | 24.9 Billion | 24.67 Billion |
| Cash at end of period | 35.21 Billion | 29.2 Billion | 30.6 Billion | 30.6 Billion | 18.01 Billion | 24.9 Billion |
| Capital Expenditure | -180.63 Million | -2.71 Billion | -819.77 Million | -5.1 Billion | -1.34 Billion | -1.6 Billion |
| Effect of forex changes on cash | -46.12 Million | -275.69 Thousand | 14.26 Million | 11.84 Thousand | -47.48 Million | -144.62 Million |
| Net cash flow / Change in cash | 6.01 Billion | -1.4 Billion | 12.59 Billion | 4.76 Billion | -6.89 Billion | 232.32 Million |
| Free Cash Flow | 7.27 Billion | -43.71 Million | 8.49 Billion | -4.26 Billion | -3.77 Billion | -7.15 Billion |
ASGR
JAIPURKURT
002498
DUVNF
ASYL
SLRN